Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
Abstract Background Trends in antimicrobial resistance help inform infection control efforts. We examined trends in resistance for Enterobacteriaceae and Acinetobacter spp. from 2013 to 2017 in hospitalized US patients. Methods We analyzed antimicrobial susceptibility of non-duplicate isolates in ho...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-019-4387-3 |
id |
doaj-5bfe489f0f124fc7a4b5260368cae126 |
---|---|
record_format |
Article |
spelling |
doaj-5bfe489f0f124fc7a4b5260368cae1262020-11-25T03:55:48ZengBMCBMC Infectious Diseases1471-23342019-08-011911910.1186/s12879-019-4387-3Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017Vikas Gupta0Gang Ye1Melanie Olesky2Kenneth Lawrence3John Murray4Kalvin Yu5Becton, Dickinson and CompanyBecton, Dickinson and CompanyTetraphase PharmaceuticalsTetraphase PharmaceuticalsBecton, Dickinson and CompanyBecton, Dickinson and CompanyAbstract Background Trends in antimicrobial resistance help inform infection control efforts. We examined trends in resistance for Enterobacteriaceae and Acinetobacter spp. from 2013 to 2017 in hospitalized US patients. Methods We analyzed antimicrobial susceptibility of non-duplicate isolates in hospitalized patients (not limited to hospital-acquired infections) in the US BD Insights Research Database. Resistance profiles of interest were extended-spectrum beta-lactamase (ESBL)-producing, multidrug resistant (MDR), and carbapenem-nonsusceptible (Carb-NS) phenotypes of Enterobacteriaceae, and MDR and Carb-NS Acinetobacter spp. Time series models were used to evaluate the patterns of resistance trends in rate per 100 hospital admissions and proportion per isolates tested. Results More than 1 million Enterobacteriaceae isolates were obtained from 411 hospitals; 12.05% were ESBL, 1.21% Carb-NS, and 7.08% MDR. Urine was the most common source. For Acinetobacter spp. (n = 19,325), 37.48% were Carb-NS, 47.66% were MDR, and the most common source was skin/wound cultures. Trend analyses showed that the rates of ESBL and Carb-NS Enterobacteriaceae per 100 hospital admissions increased significantly between 2013 and 2017. Rates of MDR Enterobacteriaceae and Carb-NS and MDR Acinetobacter spp. decreased during this time period. Trends in proportions of resistant isolates generally mirrored trends in rates per 100 hospital admissions. MDR Enterobacteriaceae and Carb-NS and MDR Acinetobacter spp. were more common in winter than summer. Conclusions In this large-scale study of patients in US hospitals, rates of ESBL and Carb-NS Enterobacteriaceae per 100 hospital admissions increased between 2013 and 2017. MDR Enterobacteriaceae and MDR and Carb-NS Acinetobacter spp. isolates decreased over this period. These data support continuing infection control and stewardship efforts and the development of new therapeutic options.http://link.springer.com/article/10.1186/s12879-019-4387-3Antimicrobial resistanceAcinetobacterEnterobacteriaceaeUnited StatesCarbapenemsExtended-spectrum beta-lactamases |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vikas Gupta Gang Ye Melanie Olesky Kenneth Lawrence John Murray Kalvin Yu |
spellingShingle |
Vikas Gupta Gang Ye Melanie Olesky Kenneth Lawrence John Murray Kalvin Yu Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017 BMC Infectious Diseases Antimicrobial resistance Acinetobacter Enterobacteriaceae United States Carbapenems Extended-spectrum beta-lactamases |
author_facet |
Vikas Gupta Gang Ye Melanie Olesky Kenneth Lawrence John Murray Kalvin Yu |
author_sort |
Vikas Gupta |
title |
Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017 |
title_short |
Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017 |
title_full |
Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017 |
title_fullStr |
Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017 |
title_full_unstemmed |
Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017 |
title_sort |
trends in resistant enterobacteriaceae and acinetobacter species in hospitalized patients in the united states: 2013–2017 |
publisher |
BMC |
series |
BMC Infectious Diseases |
issn |
1471-2334 |
publishDate |
2019-08-01 |
description |
Abstract Background Trends in antimicrobial resistance help inform infection control efforts. We examined trends in resistance for Enterobacteriaceae and Acinetobacter spp. from 2013 to 2017 in hospitalized US patients. Methods We analyzed antimicrobial susceptibility of non-duplicate isolates in hospitalized patients (not limited to hospital-acquired infections) in the US BD Insights Research Database. Resistance profiles of interest were extended-spectrum beta-lactamase (ESBL)-producing, multidrug resistant (MDR), and carbapenem-nonsusceptible (Carb-NS) phenotypes of Enterobacteriaceae, and MDR and Carb-NS Acinetobacter spp. Time series models were used to evaluate the patterns of resistance trends in rate per 100 hospital admissions and proportion per isolates tested. Results More than 1 million Enterobacteriaceae isolates were obtained from 411 hospitals; 12.05% were ESBL, 1.21% Carb-NS, and 7.08% MDR. Urine was the most common source. For Acinetobacter spp. (n = 19,325), 37.48% were Carb-NS, 47.66% were MDR, and the most common source was skin/wound cultures. Trend analyses showed that the rates of ESBL and Carb-NS Enterobacteriaceae per 100 hospital admissions increased significantly between 2013 and 2017. Rates of MDR Enterobacteriaceae and Carb-NS and MDR Acinetobacter spp. decreased during this time period. Trends in proportions of resistant isolates generally mirrored trends in rates per 100 hospital admissions. MDR Enterobacteriaceae and Carb-NS and MDR Acinetobacter spp. were more common in winter than summer. Conclusions In this large-scale study of patients in US hospitals, rates of ESBL and Carb-NS Enterobacteriaceae per 100 hospital admissions increased between 2013 and 2017. MDR Enterobacteriaceae and MDR and Carb-NS Acinetobacter spp. isolates decreased over this period. These data support continuing infection control and stewardship efforts and the development of new therapeutic options. |
topic |
Antimicrobial resistance Acinetobacter Enterobacteriaceae United States Carbapenems Extended-spectrum beta-lactamases |
url |
http://link.springer.com/article/10.1186/s12879-019-4387-3 |
work_keys_str_mv |
AT vikasgupta trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017 AT gangye trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017 AT melanieolesky trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017 AT kennethlawrence trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017 AT johnmurray trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017 AT kalvinyu trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017 |
_version_ |
1724467953821286400 |